Connect your AI

Henry Schein HSIC Share-Based Payment Award Options Outstanding - Number

Share-Based Payment Award Options Outstanding - Number at other companies

Medline, Inc. MDLN

——

Globus MedicalGMED

——

Other financials

Income statement

Revenue$3.4B+6.3%

Gross profit$1.1B+7.0%

Operating income$182.0M+4.0%

Net income$107.0M-2.7%

EPS (diluted)$0.92+4.5%

Balance sheet

Cash & equivalents$138.0M+8.7%

Total debt$3.7B+17.2%

Total equity$3.3B-1.3%

Total assets$11.3B+7.9%

Cash flow

Operating cash flow-$97.0M-362%

CapEx$25.0M-19.4%

Free cash flow-$122.0M-2,133%

Valuation

Market cap$9.1B-0.6%

Enterprise value$12.69B+4.2%

P/E23.1×+0.5×

P/S0.7×0.0×

Profitability

Gross margin31.2%-0.4pp

Operating margin4.9%-0.2pp

Net margin3%-0.3pp

FCF margin3.3%-1.0pp

Returns & leverage

Return on equity12%+0.2pp

Debt / equity1.1×+0.2×

Current ratio1.4×0.0×

Where this comes from

Reported directly by Henry Schein in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.

The official record: Henry Schein’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Henry Schein's share-based payment award options outstanding - number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Henry Schein's share-based payment award options outstanding - number?: Henry Schein (HSIC) reported share-based payment award options outstanding - number of 1.1M in Q1 2026.
What does share-based payment award options outstanding - number mean?: The total count of unexercised stock options currently held by employees and directors.
How do you interpret share-based payment award options outstanding - number?: An increase suggests higher equity-based compensation usage, while a decrease may indicate option exercises or expirations.
How does share-based payment award options outstanding - number compare across companies?: Commonly reported by public companies with stock-based incentive plans; peers often track this to monitor dilution risk.